Lord, Abbett & Co. LLC Xenon Pharmaceuticals Inc. Transaction History

Lord, Abbett & Co. LLC

$29.9 Billion
Q2 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 190,033 shares of XENE stock, worth $7.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

190,033

Previous 895,196 78.77%

Holding current value

$7.76 Million

Previous $38.5 Million 80.78%

% of portfolio

0.02%

Previous 0.13%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $25.6 Million - $30.9 Million	-705,163 Reduced 78.77%	190,033 $7.41 Million
Q1 2024 May 09, 2024	BUY	$42.66 - $50.04 $7.56 Million - $8.87 Million	177,224 Added 24.68%	895,196 $38.5 Million
Q4 2023 Feb 12, 2024	SELL	$28.7 - $46.46 $12.4 Million - $20 Million	-431,196 Reduced 37.52%	717,972 $33.1 Million
Q3 2023 Nov 13, 2023	SELL	$34.16 - $39.73 $27.6 Million - $32.2 Million	-809,372 Reduced 41.33%	1,149,168 $39.3 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $6.13 Million - $7.66 Million	175,929 Added 9.87%	1,958,540 $75.4 Million
Q1 2023 May 12, 2023	SELL	$33.46 - $40.35 $11.4 Million - $13.8 Million	-341,398 Reduced 16.07%	1,782,611 $63.8 Million
Q4 2022 Feb 10, 2023	BUY	$33.06 - $39.43 $6.95 Million - $8.29 Million	210,148 Added 10.98%	2,124,009 $83.7 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $1.73 Million - $2.24 Million	56,265 Added 3.03%	1,913,861 $69.1 Million
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $1.7 Million - $2.35 Million	66,853 Added 3.73%	1,857,596 $56.5 Million
Q1 2022 May 13, 2022	SELL	$25.09 - $33.13 $108,815 - $143,684	-4,337 Reduced 0.24%	1,790,743 $54.7 Million
Q4 2021 Feb 11, 2022	BUY	$15.6 - $35.4 $22.1 Million - $50.2 Million	1,416,722 Added 374.44%	1,795,080 $56.1 Million
Q3 2021 Nov 09, 2021	SELL	$14.86 - $19.45 $94,613 - $123,838	-6,367 Reduced 1.65%	378,358 $5.78 Million
Q2 2021 Aug 11, 2021	SELL	$16.81 - $20.0 $568,598 - $676,500	-33,825 Reduced 8.08%	384,725 $7.16 Million
Q1 2021 May 11, 2021	BUY	$13.65 - $21.31 $5.71 Million - $8.92 Million	418,550 New	418,550 $7.49 Million

Others Institutions Holding XENE

# of Institutions

221

Shares Held

69.6M

Call Options Held

59.7K

Put Options Held

60.7K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.54B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Xenon Pharmaceuticals Inc. Transaction History